Gilead Sciences
$149.05Change from previous close: −1.47%Absolute change: −$2.23
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 59,023 | 58,995 | 62,125 | 63,171 | 67,952 |
| Current assets | 18,342 | 19,173 | 16,085 | 14,443 | 14,772 |
| Cash and equivalents | 7,564 | 9,991 | 6,085 | 5,412 | 5,338 |
| Short-term investments | 2,049 | 1,577 | 2,265 | 1,446 | 2,067 |
| Receivables | 4,913 | 4,420 | 4,660 | 4,777 | 4,493 |
| Inventory | 1,774 | 1,710 | 1,787 | 1,507 | 1,618 |
| Net property, plant and equipment | 6,138 | 5,929 | 5,898 | 5,980 | 5,663 |
| Goodwill | 8,314 | 8,314 | 8,314 | 8,314 | 8,332 |
| Other intangible assets | 16,978 | 19,948 | 26,454 | 28,894 | 33,455 |
| Long-term investments | 3,753 | 713 | 1,819 | 2,611 | 2,844 |
| Current liabilities | 11,813 | 12,004 | 11,280 | 11,237 | 11,610 |
| Accounts payable | 715 | 833 | 550 | 905 | 705 |
| Long-term debt | 22,129 | 24,896 | 23,189 | 22,957 | 25,179 |
| Total debt | 24,936 | 26,711 | 24,987 | 25,230 | — |
| Total liabilities | 36,405 | 39,749 | 39,376 | 41,962 | 46,888 |
| Total equity (incl. minority) | 22,618 | 19,246 | 22,749 | 21,209 | 21,064 |
| Retained earnings | 13,730 | 11,497 | 16,304 | 15,687 | 16,324 |
| Minority interest | -84.0 | -84.0 | -84.0 | -31.0 | -5.0 |